Hemp Biotech Co. Aims To Nix Suit After 2nd Circ. Revival
A company working to bioengineer tobacco and cannabis is asking a New York federal court to toss the last remaining claims in an investor group's stock-drop suit, saying the complaint still...To view the full article, register now.
Already a subscriber? Click here to view full article